title: RS-61443 for treatment-resistant human liver rejection.
authors.affiliation: Department of Surgery, Baylor University Medical Center, Dallas, Texas.
authors.forename: G B
authors.initials: GB
authors.lastname: Klintmalm
authors.forename: N L
authors.initials: NL
authors.lastname: Ascher
authors.forename: R W
authors.initials: RW
authors.lastname: Busuttil
authors.forename: M
authors.initials: M
authors.lastname: Deierhoi
authors.forename: T A
authors.initials: TA
authors.lastname: Gonwa
authors.forename: R
authors.initials: R
authors.lastname: Kauffman
authors.forename: S
authors.initials: S
authors.lastname: McDiarmid
authors.forename: S
authors.initials: S
authors.lastname: Poplawski
authors.forename: H
authors.initials: H
authors.lastname: Sollinger
authors.forename: J
authors.initials: J
authors.lastname: Roberts
mesh_terms: D000208:Acute Disease; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004351:Drug Resistance; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010865:Pilot Projects; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D009173:Mycophenolic Acid; D001379:Azathioprine